Day: September 22, 2021

VANCOUVER, British Columbia, Sept. 22, 2021 (GLOBE NEWSWIRE) — NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQB:NAUFF) (Frankfurt:5E50) is pleased to announce that its shares will commence trading under the symbol “NAUFF” on the OTCQB Venture Market (the “OTCQB”) effective September 22, 2021. The Company has also received The Depository Trust Company (the “DTC”) full-service eligibility in the United States, making the Company’s stock more accessible to U.S. retail and institutional investors. NevGold CEO, Brandon Bonifacio, comments: “Listing on the OTCQB, along with our Frankfurt, Germany listing, enables our U.S. and European shareholders to more effectively participate in trading NevGold shares and will increase liquidity in multiple jurisdictions. With our Limousine Butte and Cedar Wash gold projects in Nevada,...

Figure 1Clinical Pipeline: MilestonesHAIFA, Israel, Sept. 22, 2021 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq: PSTI) (TASE: PSTI), a leading biotechnology company, today issued an update to its shareholders from its Chief Executive Officer and President Yaky Yanay. Dear Shareholders, Less than three months into a new fiscal year, there are several important developments on the horizon for Pluristem, including four studies heading to clinical readout in the coming quarters. These studies align with our mission to develop novel cell therapy product candidates, built using Pluristem’s advanced technology. Clinical Pipeline: Milestones During the coming year, we expect to meet multiple clinical milestones, which represent significant potential for our cellular platform. First, our Phase I study evaluating...

Pilot tests were conducted together with a leading service provider in the post-harvest space TEL AVIV, Israel, Sept. 22, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Save Foods (Nasdaq: SVFD) (“Save Foods” or the “Company”), an agrifood tech company focused on developing and selling eco-friendly products specifically designed to extend the shelf life and ensure food safety of fresh fruits and vegetables, today announced that it successfully completed a series of lemon treatment pilot tests in Spain, with a leading post-harvest service provider (“the Provider”). Spain is the leading European country in terms of lemon production, with a total of 1.2 million tons in 2020; that is 64% of the EU’s total lemon production. Spain is the largest lemon exporter in the world, accounting for approximately 27% with an estimated market...

– TMB-302 study results demonstrate that there was no difference in pharmacokinetics between IV Push and IV Infusion – – No serious adverse events observed – – sBLA filing planned for Q4 2021 – MONTREAL, Sept. 22, 2021 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that a study evaluating an intravenous (IV) push form of administration of Trogarzo® for the treatment of human immunodeficiency virus type 1 (HIV-1) infection achieved consistent and statistically significant results demonstrating that there was no difference in pharmacokinetics (PK) between IV Push and IV Infusion. Based on these results, a supplemental Biologics...

Myla Lai-Goldman, MDAkoya Biosciences appoints Myla Lai-Goldman, MD, to its Board of Directors.MARLBOROUGH, Mass., Sept. 22, 2021 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (NASDAQ: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Myla Lai-Goldman, MD, a true pioneer and leader in the diagnostic industry, to its board of directors. “It is an honor to join the board of Akoya, a company that is providing innovative spatial biology solutions with the potential to transform the life sciences market,” said Dr. Lai-Goldman. “Akoya’s platforms provide an unprecedented capability to understand the relationship of cells to their tumor microenvironment, and span applications from discovery and clinical research. The groundbreaking discoveries emanating from this work could dramatically increase...

NEWARK, Calif., Sept. 22, 2021 (GLOBE NEWSWIRE) — Rain Therapeutics Inc. (NasdaqGS: RAIN), (“Rain”), a late-stage company developing precision oncology therapeutics, today announced that Avanish Vellanki, co-founder, chairman and chief executive officer of Rain, will present at the Cantor Fitzgerald Virtual Global Healthcare Conference being held virtually September 27-30, 2021. Additional details can be found below: Date: Thursday, September 30, 2021Time: 10:00 a.m. ETLocation: Webcast Link – or at the company’s website (click here) A replay of the presentation will be available by visiting the “Events & Presentations” section of the Rain website after the conclusion of the presentation and will be archived on the Rain website for 30 days. About Rain Therapeutics Inc.Rain Therapeutics Inc. is a late-stage precision...

SANTA MONICA, Calif., Sept. 22, 2021 (GLOBE NEWSWIRE) — BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced the participation of its management team at the Cantor Virtual Global Healthcare Conference to be held September 27-30, 2021. Details on the conference can be found below. Cantor Virtual Global Healthcare ConferenceFormat: Presentation and one-on-one investor meetingsDate: Wednesday September 29, 2021Presentation Time: 11:20 a.m. ESTWebcast: https://wsw.com/webcast/cantor12/bivi/2076900 An archived webcast will also be accessible in the Investors section of the company’s website at www.bioviepharma.com. About BioVie BioVie Inc. (NASDAQ: BIVI) is a...

EVLI BANK PLC STOCK EXCHANGE RELEASE 22.9.2021 AT 3.00 PM (EET/EEST) On July 23, 2021, the European Central Bank announced that the recommendation to limit the dividend payment of banks will expire on September 30, 2021. Accordingly, Evli Bank Plc’s Board of Directors will decide on October 1, 2021 to pay the dividend in accordance with the authorization given by the Annual General Meeting 2021. The Annual General Meeting of 2021 authorized the Board of Directors to decide on a maximum dividend of EUR 0.73 per share for the financial year 2020 at the time it deems best, taking into account the current authority recommendations. The dividend record date is October 5, 2021 and the earliest possible payment date is October 12, 2021. The confirmation of the dividend payment will be announced after the Board of Directors has made a decision. EVLI...

NASHVILLE, Tenn., Sept. 22, 2021 (GLOBE NEWSWIRE) — SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced that Kyle Wailes, the Company’s Chief Financial Officer, will present at the Shareholder Equity Conference on Monday, Sept. 27, 2021 at 4:30 p.m. ET. The virtual conference is set in a fireside chat format to provide access to retail investors who will have the opportunity to ask questions during the chat. The live stream of this presentation will be webcast live and can be accessed in the “Events and Presentations” section at https://investors.smiledirectclub.com. An archived replay will be available on the Shareholder Equity Conference website for approximately 90 days following the event. About SmileDirectClubSmileDirectClub, Inc....